Methodology for evaluation of the level of IgG antibodies against different SARS-CoV-2 proteins using multiplex immunofluorescence analysis
L.V. Frolova(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), V. I. Skvortsova, S. A. Kraevoy, A.S. Zhdanova(State Research Institute of Highly Pure Biopreparations), P. G. Kazakova(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), L.A. Golubnikova(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), S. M. Yudin(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), Anton А. Keskinov(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), A.A. Mkrtchian(State Research Institute of Highly Pure Biopreparations), T. A. Shpakova(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), K. S. Grammatikati(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), В. В. Макаров(Lomonosov Moscow State University), V. S. Yudin(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), P.Yu. Zemsky(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), Natalya V. Bulanova(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), A.P. Sergeev, Ekaterina A. Snigir(Federal Agency for Health and Social Development), Sergey I. Mitrofanov(Center for Strategic Research), Yu. N. Akhmerova(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), Vladimir E. Mukhin(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), N.V. Feliz
Cited by 3
Related Papers
Biosynthesis of Stable Iron Oxide Nanoparticles in Aqueous Extracts of <i>Hordeum vulgare</i> and <i>Rumex acetosa</i> Plants
|Langmuir|2014|294
Functional Analysis of Coilin in Virus Resistance and Stress Tolerance of Potato Solanum tuberosum using CRISPR-Cas9 Editing
|Doklady Biochemistry and Biophysics|2019|124
The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia
|Genes|2021|59
Molecular Alliance of Lymantria dispar Multiple Nucleopolyhedrovirus and a Short Unmodified Antisense Oligonucleotide of Its Anti-Apoptotic IAP-3 Gene: A Novel Approach for Gypsy Moth Control
|International Journal of Molecular Sciences|2017|27